In Response to DNA Damage and C&Sol
Total Page:16
File Type:pdf, Size:1020Kb
Oncogene (2009) 28, 3235–3245 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc ORIGINAL ARTICLE C/EBPa expression is partially regulated by C/EBPb in response to DNA damage and C/EBPa-deficient fibroblasts display an impaired G1 checkpoint R Ranjan1, EA Thompson1, K Yoon2 and RC Smart1 1Cell Signaling and Cancer Group, Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC, USA and 2National Cancer Center, Division of Common Cancers, Lung Cancer Branch, Goyang-si, Gyeonggi-do, South Korea We observed that CCAAT/enhancer-binding protein involved in homo- or hetero-dimerization (Ramji and (C/EBP)a is highly inducible in primary fibroblasts by Foka, 2002). The N-terminal region contains transcrip- DNA-damaging agents that induce strand breaks, alky- tion activation and regulatory domains that interact late and crosslink DNA as well as those that produce with basal transcription apparatus and transcription bulky DNA lesions. Fibroblasts deficient in C/EBPa co-activators. There are six members of the C/EBP family À/À (C/EBPa ) display an impaired G1 checkpoint as and C/EBPs have important functions in fundamental evidenced by an inappropriate entry into the S-phase in cellular processes, including proliferation, apoptosis, response to DNA damage, and these cells also display an differentiation, inflammation, senescence and energy enhanced G1/S transition in response to mitogens. The metabolism (Ramji and Foka, 2002; Johnson, 2005). induction of C/EBPa by DNA damage in fibroblasts does C/EBPa mediates cell-cycle arrest associated with not require p53. Electrophoretic mobility shift assay terminal differentiation in adipocytes (Umek et al., (EMSA) analysis of nuclear extracts prepared from 1991; Lin and Lane, 1994), hepatocytes (Diehl et al., ultraviolet B (UVB)- and N-methyl-N0-nitro-N-nitroso- 1996) and myeloid cells (Radomska et al., 1998; Wang guanidine (MNNG)-treated fibroblasts showed increased et al., 1999) and it regulates the expression of genes binding of C/EBPb to a C/EBP consensus sequence associated with the differentiated phenotype in these cell and chromatin immunoprecipitation (ChIP) analysis also types. Consistent with its role in the regulation of showed increased C/EBPb binding to the C/EBPa differentiation, C/EBPa has been shown to be a tumor promoter. To determine whether C/EBPb has a function suppressor gene in acute myeloid leukemia, in which it is in the regulation of C/EBPa, we treated C/EBPbÀ/À inactivated in B9% of AML cases through specific fibroblasts with UVB or MNNG. We observed that somatic mutations (Pabst et al., 2001; Gombart et al., C/EBPa induction was impaired in both UVB- and 2002). The inactivating mutations in C/EBPa result MNNG-treated C/EBPbÀ/À fibroblasts. Our study shows in a block in granulocytic differentiation and contribute a novel function for C/EBPb in the regulation of C/EBPa to the uncontrolled proliferation of undifferentiated in response to DNA damage and provides definitive immature granulocytic blasts. Ectopic or forced expres- genetic evidence that C/EBPa has a critical role in the sion of C/EBPa inhibits cell-cycle progression in nearly DNA damage G1 checkpoint. all cell types examined (Hendricks-Taylor and Darling- Oncogene (2009) 28, 3235–3245; doi:10.1038/onc.2009.176; ton, 1995; Watkins et al., 1996; Halmos et al., 2002; published online 6 July 2009 Johnson, 2005; Shim et al., 2005); however, the intrinsic cellular signals and pathways that regulate C/EBPa Keywords: C/EBP; DNA damage response; G1/S transi- expression and its growth arrest properties are not fully tion; p53 understood. In some cases, these pathways are linked to cellular differentiation. C/EBPa expression is ablated or greatly diminished in a number of epithelial cancers, including lung (Halmos Introduction et al., 2002), skin (Oh and Smart, 1998; Shim et al., 2005), liver (Xu et al., 2001), head and neck (Bennett The CCAAT/enhancer-binding proteins (C/EBPs) are et al., 2007), endometrial (Takai et al., 2005) and breast members of the basic leucine zipper (bZIP) class of (Gery et al., 2005), suggesting a tumor suppressor transcription factors that contain a C-terminal basic function. In many cases, the C/EBPa gene is silenced DNA-binding domain and a leucine zipper domain through promoter hypermethylation (Gery et al., 2005; Tada et al., 2006; Bennett et al., 2007). Causal or genetic evidence for a suppressor role of C/EBPa in epithelial Correspondence: Dr RC Smart, Cell Signaling and Cancer Group, tumorigenesis is lacking because of the absence of Department of Environmental and Molecular Toxicology, North C/EBPa mutations in epithelial tumors. Moreover, Carolina State University, Raleigh, NC 27695-7633, USA. E-mail: [email protected] genetically engineered mouse models to document the Received 23 December 2008; revised 23 May 2009; accepted 24 May suppressor function of C/EBPa in tumorigenesis 2009; published online 6 July 2009 have been problematic as germ line or lung-specific C/EBPa is regulated by C/EBPb in response to DNA damage R Ranjan et al 3236 deletion of C/EBPa is perinatally lethal (Wang et al., 1995; types of DNA damage with the induction of C/EBPa, Basseres et al., 2006). Recently, a genetically engineered and we present genetic evidence using C/EBPaÀ/À cells to mouse model in which C/EBPa was ablated in the show a role for C/EBPa in the G1 checkpoint. epidermis was successfully developed (Loomis et al., Importantly, we have identified a novel stress pathway, 2007). These mice survived and were highly susceptible in which C/EBPb has a role in the induction of C/EBPa to carcinogen-induced skin tumorigenesis, thus provid- in response to DNA damage. ing the first genetic evidence for C/EBPa as a suppressor of epithelial tumorigenesis. Surprisingly, the epidermal- specific C/EBPa knockout mice did not show alterations Results in stratified squamous differentiation or proliferation of epidermal keratinocytes, suggesting that their enhanced UVB induces C/EBPa in fibroblasts and C/EBPaÀ/À susceptibility to tumorigenesis is not related to alterations fibroblasts display alterations in the G1/S transition in keratinocyte differentiation (Loomis et al., 2007). and G1 checkpoint To prevent or reduce stress-induced injury and Initially, we attempted cell-cycle studies in wild-type cellular damage, cells have evolved intricate pathways and C/EBPaÀ/À primary keratinocytes; however, these that permit them to respond to both intrinsic and studies were not informative because of the inherent extrinsic stressors. In terms of DNA damage, cells complexity of using primary keratinocytes for cell-cycle respond by engaging cell-cycle checkpoints and repair- regulation studies owing to the presence of mixed ing damaged DNA in order to maintain genome populations of differentiating and proliferating primary integrity and to prevent heritable mutations, which can keratinocytes. To provide direct genetic evidence for lead to genomic instability, aging and cancer (Kastan C/EBPa in the G1 checkpoint and to extend the findings and Bartek, 2004; Sancar et al., 2004; Ishikawa et al., on UVB-induced expression of C/EBPa in keratinocytes 2006). In ultraviolet B (UVB)-treated skin keratinocytes, to another cell type, mouse dermal wild-type and C/EBPa expression is highly induced through a p53- C/EBPaÀ/À primary fibroblasts were used. Wild-type dependent pathway and the partial small interfering and C/EBPaÀ/À primary fibroblasts were exposed to a RNA (siRNA) knockdown of C/EBPa in the BALB/ single dose of UVB radiation (5 mJ/cm2). UVB radiation MK2 keratinocyte cell line resulted in a diminished produced a significant increase in C/EBPa protein levels G1 checkpoint after UVB-induced DNA damage in wild-type fibroblasts (Figure 1a) and C/EBPa was (Yoon and Smart, 2004). Although C/EBPa was highly not expressed in C/EBPaÀ/À fibroblasts (Figure 1b). In induced by UVB in keratinocytes, UVB treatment wild-type fibroblasts, C/EBPa was maximally induced at of HepG2, NRK and NIH3T3 cells failed to induce 6 h post UVB treatment and returned to control levels C/EBPa. Thus, C/EBPa, at least in keratinocytes, is by 24 h post UVB treatment. Elevated levels of C/EBPa regulated by stress involving DNA damage through a were detected as early as 1 h post UVB treatment (data p53 pathway, and it appears to have a role in the not shown). UVB also induced a modest transient maintenance of genomic stability through its role in the increase in C/EBPb at 6 h post UVB treatment G1 checkpoint. However, genetic evidence supporting a (Figure 1a). role for C/EBPa in the G1 checkpoint is lacking, and as To examine the effect of the genetic ablation of mentioned above, no other cell types other than C/EBPa on cell-cycle regulation, wild-type and keratinocytes have been reported to respond to DNA C/EBPaÀ/À and primary fibroblasts were synchronized damage with the induction of C/EBPa. by serum deprivation and then released into the cell In light of C/EBPa’s role in tumorigenesis and DNA cycle by the addition of serum-containing media. damage response, it is important to understand the Fibroblasts were either left untreated or treated with a stress pathways or mechanisms through which C/EBPa single dose of UVB (5 mJ/cm2) 4 h after release. Cells is regulated in response to DNA damage and the were pulsed with 5-bromo-20-deoxyuridine (BrdU) 1 h functional importance of C/EBPa’s induction. In this before each collection time point (4, 15, 18, 21 and 24 h study, we show that fibroblasts respond to multiple post release) and fluorescence-activated cell sorting Figure 1 Ultraviolet B (UVB) radiation induces C/EBPa in primary fibroblasts and C/EBPa is involved in the G1/S transition as well as in 2 UVB-induced G1 checkpoint.